Old Web
English
Sign In
Acemap
>
authorDetail
>
Yoko Murata
Yoko Murata
Pfizer
Internal medicine
Prostaglandin
Pharmacology
Chemistry
Endocrinology
5
Papers
130
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Effects of the selective EP4 antagonist, CJ‐023,423 on chronic inflammation and bone destruction in rat adjuvant‐induced arthritis
2008
Journal of Pharmacy and Pharmacology
Takako Okumura
Yoko Murata
Kana Taniguchi
Akio Murase
Aisuke Nii
Show All
Source
Cite
Save
Citations (25)
Mathematical analysis of involvement ratio between central and peripheral COX-2 in rat pain models with two types of COX-2 inhibitors with different distribution, celecoxib and CIAA
2008
Acute Pain
Takako Okumura
Ayano Sakakibara
Yoko Murata
Yasuhiro Kita
Show All
Source
Cite
Save
Citations (2)
Mathematical analysis of involvement ratio between central and peripheral COX-2 in rat pain models with two types of COX-2 inhibitors with different distribution, celecoxib and CIAA
2008
European Journal of Pharmacology
Takako Okumura
Ayano Sakakibara
Yoko Murata
Yasuhiro Kita
Show All
Source
Cite
Save
Citations (2)
CJ-023,423, a Novel, Potent and Selective Prostaglandin EP4 Receptor Antagonist with Antihyperalgesic Properties
2007
Journal of Pharmacology and Experimental Therapeutics
Kazunari Nakao
Akio Murase
Hiroyuki Ohshiro
Takako Okumura
Kana Taniguchi
Yoko Murata
Masatoshi Masuda
Tomoki Kato
Yoshiyuki Okumura
Junji Takada
Show All
Source
Cite
Save
Citations (91)
Pharmacological separation between peripheral and central functions of cyclooxygenase-2 with CIAA, a novel cyclooxygenase-2 inhibitor.
2006
European Journal of Pharmacology
Takako Okumura
Yoko Murata
Masanori Hizue
Tomomi Matsuura
Rie Naganeo
Yoshihito Kanai
Akio Murase
Ayano Sakakibara
Isami Fujita
Kazunari Nakao
Show All
Source
Cite
Save
Citations (10)
1